Lazarus Enterprises, Inc. – Trademark Portfolio
Entity Type: 03
Lazarus Enterprises, Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 2 are pending. Notable registered marks include TRAMADEN, ZANAPRIN, DIAZAPRIN, PHENTERAMIN, and LAZARUS LABS. The owner is based in Cartersville, GA.
52 Latimer Lane NW
Cartersville, GA 30121
Showing of trademarks Trademarks
Trademark Classifications
Lazarus Enterprises, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Lazarus Enterprises, Inc. have?
Lazarus Enterprises, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 pending, 3 abandoned, 2 cancelled.
What trademark classes does Lazarus Enterprises, Inc. file in?
Lazarus Enterprises, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Lazarus Enterprises, Inc.'s most well-known trademarks?
Lazarus Enterprises, Inc.'s registered trademark portfolio includes well-known marks such as TRAMADEN, ZANAPRIN, DIAZAPRIN, PHENTERAMIN, and LAZARUS LABS. These are among 5 currently registered trademarks in the portfolio.
What is Lazarus Enterprises, Inc.'s trademark registration success rate?
Lazarus Enterprises, Inc. has a 50% trademark registration rate, with 5 out of 10 resolved applications resulting in successful registration. Currently, 2 applications are pending review.